Clinicopathological Features and Treatment Challenges in Triple Negative Breast Cancer Patients: A Retrospective Cohort Study

Objective: As the genetic and molecular profiles of triple negative breast carcinoma (TNBC) are elucidated, multiple therapeutic targets have been produced. TNBC with less than 1% androgen receptor (AR) expression may respond to enzalutamide with greater response association in higher levels. A metr...

Full description

Bibliographic Details
Main Authors: Amira ELWAN, Aziza E. ABDELRAHMAN, Ahmed A. ALNAGAR, Mohamed I ABDELHAMID, Nashwa NAWAR
Format: Article
Language:English
Published: Federation of Turkish Pathology Societies 2021-05-01
Series:Türk Patoloji Dergisi
Subjects:
Online Access: http://www.turkjpath.org/pdf.php3?id=1951